{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:36:08Z","timestamp":1783956968153,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We report our findings in a patient who developed central retinal vein occlusion (CRVO) and was a chronic user of olanzapine, an antipsychotic medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 50-year-old Caucasian man, non-smoker, was referred to our clinic with the chief complaint of floater appearance in his left eye for the past 3 days. His past medical history indicated that he had been taking antipsychotic drugs (olanzapine) for about 3 years, with no other systemic disease or risk factors for CRVO.<\/jats:p>\n                <jats:p>In the examination, his best-corrected visual acuity (BCVA) was 0.7 in the left eye. The fundus showed signs of nonischemic CRVO with subhyaloid hemorrhage and intraretinal hemorrhage in the posterior pole and superior and inferior retina, without macular edema, confirmed by optical coherence tomography (OCT).<\/jats:p>\n                <jats:p>We ruled out other probable differential diagnoses and risk factors which lead to CRVO through a complete physical exam and blood analysis (complete blood count, glucose, urea, creatinine, lipid profile, erythrocyte sedimentation rate, C-reactive protein, prothrombin time, partial thromboplastin time, Bleeding time (BT), fibrinogen level, proteins, antiphospholipid antibodies, homocysteine blood level, antithrombin III, protein C and S, factor V Leiden, prothrombin mutation, angiotensin-converting enzyme level, other autoantibodies, and human leukocyte antigen [HLA]-B51). Finally, we confirmed the probable side effect of olanzapine in CRVO, which has not been previously reported. A possible pro-thrombogenic mechanism of olanzapine at the molecular level is an affinity for 5-HT<jats:sub>2A<\/jats:sub>serotonin receptors. Blocking these receptors results in increased platelet aggregation and increased blood coagulability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results indicate that CRVO can be a complication of chronic use of antipsychotic medications such as olanzapine, as shown for the first time in our case report. Clinicians should question patients who develop a sudden CRVO whether they are using antipsychotic medications such as olanzapine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02865-8","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:14:07Z","timestamp":1622243647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-091X","authenticated-orcid":false,"given":"Ali","family":"Nowrouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Kafiabasabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rodriguez-Calzadilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Benitez-del-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soto-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Diaz-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyara Vaneska","family":"Marques-Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1192\/bjp.180.1.85","volume":"180","author":"F Curtin","year":"2002","unstructured":"Curtin F, Blum M. Antipsychotics and risk of venous thrombosis. Br J Psychiatry. 2002;180:85.","journal-title":"Br J Psychiatry."},{"key":"2865_CR2","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1001\/archinte.165.22.2677","volume":"165","author":"R Liperoti","year":"2005","unstructured":"Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med. 2005;165:2677\u201382.","journal-title":"Arch Intern Med."},{"key":"2865_CR3","first-page":"205","volume":"88","author":"JG Ray","year":"2002","unstructured":"Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. ThrombHaemost. 2002;88:205\u20139.","journal-title":"ThrombHaemost."},{"key":"2865_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1192\/bjp.179.1.63","volume":"179","author":"R Thomassen","year":"2001","unstructured":"Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry. 2001;179:63\u20136.","journal-title":"Br J Psychiatry."},{"key":"2865_CR5","doi-asserted-by":"publisher","first-page":"c4245","DOI":"10.1136\/bmj.c4245","volume":"341","author":"C Parker","year":"2010","unstructured":"Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.","journal-title":"BMJ"},{"key":"2865_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.4088\/JCP.12m08117","volume":"74","author":"CS Wu","year":"2013","unstructured":"Wu CS, Lin CC, Chang CM, Wu KY, Liang HY, Huang YW, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013;74:918\u201324.","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2865_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000479219","volume":"8","author":"K Taki","year":"2017","unstructured":"Taki K, Kida T, Fukumoto M, Sato T, Oku H, Ikeda T. Central retinal vein occlusion in 2 patients using antipsychotic drugs. Case Rep Ophthalmol. 2017;8(2):410\u20135.","journal-title":"Case Rep Ophthalmol."},{"key":"2865_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13167-010-0025-2","volume":"1","author":"SA Fraenkl","year":"2010","unstructured":"Fraenkl SA, Mozaffarieh M, Flammer J. Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J. 2010;1:253\u201361.","journal-title":"EPMA J."},{"key":"2865_CR9","first-page":"281","volume":"56","author":"JP Ehlers","year":"2011","unstructured":"Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. SurvOphthalmol. 2011;56:281\u201399.","journal-title":"SurvOphthalmol."},{"key":"2865_CR10","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","volume":"8","author":"M Rehak","year":"2010","unstructured":"Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J ThrombHaemost. 2010;8:1886\u201394.","journal-title":"J ThrombHaemost."},{"key":"2865_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1001\/archinte.1978.03630260030012","volume":"138","author":"MA McGrath","year":"1978","unstructured":"McGrath MA, Wechsler F, Hunyor AB, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med. 1978;138:216\u201320.","journal-title":"Arch Intern Med."},{"issue":"10","key":"2865_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/bjo.2008.140640","volume":"92","author":"LL Lim","year":"2008","unstructured":"Lim LL, Cheung N, Wang JJ, Islam FM, Mitchell P, Saw SM, Aung T, Wong TY. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol. 2008;92(10):1316\u20139.","journal-title":"Br J Ophthalmol."},{"key":"2865_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-244X-11-2","volume":"11","author":"J Masopust","year":"2011","unstructured":"Masopust J, Maly R, Andrys C, Valis M, Bazant J, Hosak L. Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry. 2011;11:2. https:\/\/doi.org\/10.1186\/1471-244X-11-2.","journal-title":"BMC Psychiatry"},{"key":"2865_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-018-0495-7","volume":"32","author":"AK Jonsson","year":"2018","unstructured":"Jonsson AK, Schill J, Olsson H, Spigset O, Hagg S. Venous thromboembolism during treatment with antipsychotics: a review of current evidence. CNS Drugs. 2018;32:47\u201364. https:\/\/doi.org\/10.1007\/s40263-018-0495-7.","journal-title":"CNS Drugs"},{"key":"2865_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ICB.0b013e3180601196","volume":"2","author":"A Agca","year":"2008","unstructured":"Agca A, Bayraktar Z, Cakr M, Bayraktar S, Ekinci O, Ylmaz OF. Central retinal vein occlusion in a young adult during risperidone therapy. Retin Cases Brief Rep. 2008;2:199\u2013201.","journal-title":"Retin Cases Brief Rep."},{"key":"2865_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2415-11-24","volume":"11","author":"KC Yong","year":"2011","unstructured":"Yong KC, Kah TA, Ghee YT, Siang LC, Bastion ML. Branch retinal vein occlusion associated with quetiapine fumarate. BMC Ophthalmol. 2011;11:24.","journal-title":"BMC Ophthalmol."},{"key":"2865_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1538-7836.2008.03234.x","volume":"7","author":"KH Borch","year":"2009","unstructured":"Borch KH, Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Troms\u00f8 study. J ThrombHaemost. 2009;7:739\u201345. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03234.x.","journal-title":"J ThrombHaemost"},{"key":"2865_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fpsyt.2019.00330","volume":"10","author":"J Masopust","year":"2019","unstructured":"Masopust J, Bazantova V, Kuca K, Klimova B, Valis M. Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series. Front Psychiatry. 2019;10:330.","journal-title":"Front Psychiatry."},{"key":"2865_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/070674370505000214","volume":"50","author":"NH Bhanji","year":"2005","unstructured":"Bhanji NH, Chouinard G, Hoffman L, Margolese HC. Seizures, coma, and coagulopathy following olanzapine overdose. Can J Psychiatry. 2005;50:126\u20137. https:\/\/doi.org\/10.1177\/070674370505000214.","journal-title":"Can J Psychiatry"},{"key":"2865_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.jcp.0000088914.24613.51","volume":"23","author":"H Wallaschofski","year":"2003","unstructured":"Wallaschofski H, Eigenthaler M, Kiefer M, Donne M, Hentschel B, Gertz HJ, et al. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. J ClinPsychopharmacol. 2003;23:479\u201383. https:\/\/doi.org\/10.1097\/01.jcp.0000088914.24613.51.","journal-title":"J ClinPsychopharmacol"},{"key":"2865_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/j.1538-7836.2012.04828.x[","volume":"10","author":"SC Christiansen","year":"2012","unstructured":"Christiansen SC, Lijfering WM, Naess IA, Hammerstrom J, van Hylckama VA, Rosendaal FR, et al. The relationship between body mass index, activated protein C resistance and risk of venous thrombosis. J ThrombHaemost. 2012;10:1761\u20137. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04828.x[.","journal-title":"J ThrombHaemost"},{"key":"2865_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0024-3205(93)90671-O","volume":"53","author":"F Cerrito","year":"1993","unstructured":"Cerrito F, Lazzaro MP, Gaudio E, Arminio P, Aloisi G. 5HT2-receptors and serotonin release: their role in human platelet aggregation. Life Sci. 1993;53:209\u201315.","journal-title":"Life Sci."},{"key":"2865_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med. 2011;208:961\u201372.","journal-title":"J Exp Med."},{"key":"2865_CR24","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00417-014-2617-3","volume":"252","author":"M Mozaffarieh","year":"2014","unstructured":"Mozaffarieh M, Bartschi M, Henrich PB, Schoetzau A, Flammer J. Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions. Graefes Arch ClinExpOphthalmol. 2014;252:1569\u201371.","journal-title":"Graefes Arch ClinExpOphthalmol."},{"key":"2865_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13167-015-0043-1","volume":"6","author":"J Flammer","year":"2015","unstructured":"Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:21.","journal-title":"EPMA J."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02865-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:30:33Z","timestamp":1622244633000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02865-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests and confirm that all relevant data are included in the case presentation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}